Roshan Abraham

Roshan covers India's startup and VC ecosystem from Bengaluru. Formerly at Reuters, he focused on equity markets, Wall Street insights, commodities, and led COVID data efforts. Outside work, he enjoys music, playing the keyboard, and watching movies and TV series.

Premium
Deals Digest: PE/VC deal activity cools, M&A volumes rise

General

17 October, 2025

Deals Digest: PE/VC deal activity cools, M&A volumes rise

Private equity (PE) and venture capital (VC) deal activity moderated in the week ending October 17, data collated by ......

Premium

Healthcare

17 October, 2025

HealthKois' Ajay Mahipal on new fund's investment thesis, return expectations and more

Healthcare-focused investment firm HealthKois, which is led by the team that managed HealthQuad funds I and II, is on ......

Healthcare

16 October, 2025

L Catterton picks up minority stake in proctology-focused clinic

Global consumer-focused private equity firm L Catterton, which last month made the first close of its India-focused fund......

TMT

16 October, 2025

Graph AI, Dashamlabs, Everbright, FireAI, two others collect early-stage cheques

AI startup Graph, managed services platform Everbright Health, insulation material maker Dashamlabs, and business ......

Pro

Healthcare

09 October, 2025

Kotak Alts-backed Matrix Pharma buys bulk-drugs maker

Bulk-drugs maker Matrix Pharmacorp Pvt Ltd has struck a deal to take control of an Indian company, two years after ......

Premium

Healthcare

09 October, 2025

Bottomline: Expansion pains hit Paras Healthcare as losses widen, growth slows

Paras Healthcare Ltd, which operates a chain of multi-specialty hospitals across northern India and is eyeing a public ......

Pro

Healthcare

08 October, 2025

General Atlantic changes tack to monetize India healthcare bet

Private equity firm General Atlantic has changed its game plan to monetize its investment in an Indian company that it ......

Healthcare

06 October, 2025

Eight Roads-backed Plasmagen Biosciences hires former Abbott exec as CEO

Eight Roads Ventures-backed biopharmaceutical firm Plasmagen Biosciences has named a former Abbott India senior ......

Premium

General

03 October, 2025

Grapevine: Kotak Alts, Zepto, CalPERS, General Catalyst, Blackstone in news

The Kotak Mahindra Group’s alternative investment arm is looking to raise a new fund while Blackstone has reached the ......

Healthcare

01 October, 2025

PE-backed Indegene to acquire US firm for $106 mn

Life sciences and healthcare services company Indegene Ltd, which counts private equity firm Brighton Park Capital and ......